Monday, January 18, 2010
More claims vs Pfizer for smoking quitting drug
Chantix, a popular smoking cessation drug manufactured by Pfizer, Inc., was approved by the FDA in 2006 as a prescription treatment to help people quit smoking. However, shortly after Chantix was introduced, adverse event reports linked the drug to an increased risk of severe psychological side effects, such as depression, suicidal thoughts and other abnormal behavior. More than 50 lawsuits related to the effects of Chantix are now pending. The three more recent ones were filed last week in New York state court against Pfizer. The cases were filed on behalf of individuals who claim that side effects of Chantix caused users to commit or attempt suicide, adding to the mounting number of similar suits filed against the drug maker in both state and federal courts. For more on this story go here.